Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
22.37
+0.25 (1.15%)
May 28, 2026, 1:31 PM EDT - Market open
Immunome Employees
Immunome had 206 employees as of March 31, 2026. The number of employees increased by 75 or 57.25% compared to the same quarter last year.
Employees
206
Change
75
Growth
57.25%
Revenue / Employee
$19,490
Profits / Employee
-$1,090,257
Market Cap
2.53B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 206 | 75 | 57.25% |
| Dec 31, 2025 | 177 | 59 | 50.00% |
| Sep 30, 2025 | 168 | 63 | 60.00% |
| Jun 30, 2025 | 155 | 77 | 98.72% |
| Mar 31, 2025 | 131 | 69 | 111.29% |
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Sep 30, 2024 | 105 | 50 | 90.91% |
| Jun 30, 2024 | 78 | - | - |
| Mar 31, 2024 | 62 | 25 | 67.57% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Tarsus Pharmaceuticals | 370 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Alumis | 227 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
| IDEAYA Biosciences | 145 |
IMNM News
- 3 hours ago - Immunome price target raised to $37 from $36 at Truist - TheFly
- 8 hours ago - Immunome initiated with an Overweight at Barclays - TheFly
- 1 day ago - Immunome to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
- 13 days ago - Immunome price target lowered to $33 from $37 at Leerink - TheFly
- 15 days ago - Immunome reports Q1 EPS (48c), consensus (54c) - TheFly
- 15 days ago - Immunome Reports First Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 15 days ago - Immunome Earnings release: Q1 2026 - Filings
- 15 days ago - Immunome Quarterly report: Q1 2026 - Filings